Dolby Laboratories, Inc. (NYSE:DLB - Free Report) - Equities research analysts at Zacks Research cut their Q1 2026 EPS estimates for shares of Dolby Laboratories in a report released on Tuesday, October 29th. Zacks Research analyst V. Doshi now forecasts that the electronics maker will post earnings of $0.71 per share for the quarter, down from their previous estimate of $0.72. The consensus estimate for Dolby Laboratories' current full-year earnings is $2.71 per share. Zacks Research also issued estimates for Dolby Laboratories' Q2 2026 earnings at $0.74 EPS and FY2026 earnings at $2.81 EPS.
Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its earnings results on Wednesday, August 7th. The electronics maker reported $0.47 EPS for the quarter, beating analysts' consensus estimates of $0.33 by $0.14. Dolby Laboratories had a net margin of 16.87% and a return on equity of 10.66%. The company had revenue of $288.82 million for the quarter, compared to analysts' expectations of $286.26 million.
Separately, Barrington Research reaffirmed an "outperform" rating and set a $100.00 price objective on shares of Dolby Laboratories in a research report on Friday, September 20th.
Get Our Latest Report on DLB
Dolby Laboratories Trading Up 1.0 %
DLB traded up $0.75 during mid-day trading on Friday, hitting $73.65. 198,660 shares of the stock were exchanged, compared to its average volume of 401,029. The firm's fifty day moving average is $72.89 and its two-hundred day moving average is $76.49. Dolby Laboratories has a 1-year low of $66.35 and a 1-year high of $90.06. The company has a market cap of $7.02 billion, a PE ratio of 33.63 and a beta of 0.97.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Blue Trust Inc. boosted its holdings in shares of Dolby Laboratories by 398.8% in the second quarter. Blue Trust Inc. now owns 414 shares of the electronics maker's stock valued at $35,000 after acquiring an additional 331 shares in the last quarter. Point72 Hong Kong Ltd acquired a new position in Dolby Laboratories during the 2nd quarter worth approximately $37,000. GAMMA Investing LLC raised its stake in shares of Dolby Laboratories by 64.6% during the 2nd quarter. GAMMA Investing LLC now owns 489 shares of the electronics maker's stock worth $39,000 after buying an additional 192 shares in the last quarter. Whittier Trust Co. of Nevada Inc. lifted its holdings in shares of Dolby Laboratories by 192.4% in the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 576 shares of the electronics maker's stock valued at $46,000 after buying an additional 379 shares during the period. Finally, Headlands Technologies LLC boosted its stake in shares of Dolby Laboratories by 693.3% in the first quarter. Headlands Technologies LLC now owns 595 shares of the electronics maker's stock valued at $50,000 after buying an additional 520 shares in the last quarter. 58.56% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other news, CEO Kevin J. Yeaman sold 28,512 shares of Dolby Laboratories stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $74.12, for a total value of $2,113,309.44. Following the transaction, the chief executive officer now directly owns 83,721 shares of the company's stock, valued at $6,205,400.52. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 39.54% of the stock is owned by company insiders.
Dolby Laboratories Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, August 27th. Shareholders of record on Monday, August 19th were issued a dividend of $0.30 per share. The ex-dividend date was Monday, August 19th. This represents a $1.20 dividend on an annualized basis and a yield of 1.63%. Dolby Laboratories's payout ratio is currently 54.79%.
Dolby Laboratories announced that its board has approved a share repurchase program on Wednesday, August 7th that authorizes the company to buyback $350.00 million in outstanding shares. This buyback authorization authorizes the electronics maker to reacquire up to 5% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's management believes its shares are undervalued.
About Dolby Laboratories
(
Get Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
See Also
Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
